- Stocks
- Healthcare
EUDA
EUDA Health Holdings Limited
EUDA
NASDAQ·Healthcare·Medical - Care Facilities·Mkt cap $25.2M
$13.49
▼ -6.32%
P/E
-11.43
Mkt Cap
$25.2M
52-Wk Range
$5.26–$86.00
52-Week Range
$5.26 - $86.00
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 55.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Early-mover advantage in Asian telehealth market
- Proprietary digital health platform technology
- Strategic subsidiary backing from Watermark Developments
- Streamlined non-emergency medical consultation process
Bear Case
1 risk
- Low volatility (beta 0.6).
Growth
Turning profitable
Increasing adoption of telehealth services post-pandemic
Value
Deep value opportunity - significant discount to Healthcare IT & Services peers
Momentum
Weak
-12.7% over 3m
Quality
Strong
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying EUDA right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Most recent quarter reported revenue of $1.5M (+60% YoY). Reported EPS of -$0.32. Gross margin 27.3%.
Reported EPS · last 4Q
Q2 25
-$0.32
Q1 25
-$0.32
Q4 24
-$0.25
Q3 24
-$0.28
Revenue trend · last 8Q
—
—
—
-14%
-5%
+10%
+60%
+60%
Q2 23
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
$1.1M
$951.7K
$954.0K
$954.0K
$1.1M
$1.1M
$1.5M
$1.5M
Margins · last 8Q
Gross
27.3%
Operating
-37.0%
Profit
-39.4%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How EUDA stacks vs Medical - Care Facilities
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related